reports
- Tijs Hollestelle
DEME Group/Mind the 2028 gap/HOLD (previously Buy)
We downgrade the stock from Buy to HOLD and lower our target price from €195.00 to €182.25 expecting earnings momentum to turn negative in 2027-28F. DEME reported better-than-expected 2H25 results and provided a 2026 outlook that exceeded our expectations. This coincided with EU politicians stepping up their commitments to install more MW offshore wind energy towards 2029-30. Looking at the supply chain, we see early cyclical offshore wind players struggling with low order intake and low activit...
- Ahmed Ben Salem
- Thomas Zlowodzki
EQNR EQUINOR ASA
PROX PROXIMUS SA DE DROIT PUBLIC
GALP GALP ENERGIA SGPS SA CLASS B
BVI BUREAU VERITAS SA
SDG SYNERGIE SA
ITRK INTERTEK GROUP PLC
ENI ENI S.P.A.
MBB MBB INDUSTRIES SE
NANO NANOBIOTIX SA
REP REPSOL SA
ARG ARGAN SA
IDR INDRA SISTEMAS S.A. CLASS A
BP. BP P.L.C.
DMP DERMAPHARM HOLDING SE
ERF EUROFINS SCIENTIFIC SOCIETE EUROPEENNE
ANR ANSWEAR.COM
AERO MONTANA AEROSPACE AG
SHEL SHELL PLC
SGSN SGS SA
- Ahmed Ben Salem
- Thomas Zlowodzki
EQNR EQUINOR ASA
PROX PROXIMUS SA DE DROIT PUBLIC
GALP GALP ENERGIA SGPS SA CLASS B
BVI BUREAU VERITAS SA
SDG SYNERGIE SA
ITRK INTERTEK GROUP PLC
VETO VETOQUINOL SA
ENI ENI S.P.A.
MBB MBB INDUSTRIES SE
NANO NANOBIOTIX SA
REP REPSOL SA
ARG ARGAN SA
IDR INDRA SISTEMAS S.A. CLASS A
BP. BP P.L.C.
DMP DERMAPHARM HOLDING SE
ERF EUROFINS SCIENTIFIC SOCIETE EUROPEENNE
ANR ANSWEAR.COM
AERO MONTANA AEROSPACE AG
SHEL SHELL PLC
SGSN SGS SA
- Guy Sips
- Jacob Mekhael
- Kristof Samoy
- Livio Luyten
- Michiel Declercq
- Thibault Leneeuw
- Thomas Couvreur
- Wim Hoste
- Wim Lewi
Dynamic Top Pick List Update April 2026: Adding Fagron
The tariff war between US and China has eased, but with the Iran conflict and an erratic Trump, uncertainty will continues unabated. Energy prices have gone ballistic, with gas prices doubling in Europe and has hit the cyclical stocks hard. KBC macro-econimists have hiked the inflation expectation for 2026 from 1.9% to 3.3%. While the macro-economic impact has been limited so far, a prolonged uncertain situation will result in economic damage. We continue our defensive stance in our Benelux Dyna...
FAGR FAGRON SA
WKL WOLTERS KLUWER NV
EVS EVS BROADCAST EQUIPMENT SA
UCB UCB S.A.
DIE D'IETEREN SA
SOF SOFINA SA
IBAB ION BEAM APPLICATIONS SA
ROYAL VOPAK NV
CSM CORBION NV
ABI ANHEUSER-BUSCH INBEV SA/NV
ARGX ARGEN-X SE
WDP WAREHOUSES DE PAUW SCA
AZE AZELIS GROUP NV
DEME DEME GROUP NV
SHUR SHURGARD SELF STORAGE LIMITED
- Konrad Zomer
- Jan Frederik Slijkerman
Proximus/Global business performance remains a challenge
Proximus continues to show a solid domestic performance. The Global division, however, continues to encounter headwinds with the story, for now, developing from an opportunity into a problem. Domestic competition remains a source of uncertainty, although near-term revenue visibility remains high. It is too early to expect a turnaround, while Proximus' notes offer limited value, in our view.
DEME announces start of new share buyback program
DEME announces start of new share buyback program Based on the shareholder authorization granted by the Extraordinary General Meeting of May 21, 2025, the Board of Directors of DEME Group NV has decided to launch a new share buyback program. Attachment
DEME kondigt start nieuw inkoopprogramma eigen aandelen aan
DEME kondigt start nieuw inkoopprogramma eigen aandelen aan Op basis van de door de Buitengewone Algemene Vergadering van 21 mei 2025 verleende machtiging van de aandeelhouders, heeft de Raad van Bestuur van DEME Group NV besloten een nieuw inkoopprogramma van eigen aandelen op te starten. Bijlage
- Jacob Mekhael
Galapagos Signs agreement with Gilead on T-cell Engager in autoimmune ...
Galapagos announced that, following Gilead entering into a definitive agreement to acquire Ouro Medicines for $1,675m in cash consideration, and up to $500m in contingent milestone payments, Galapagos and Gilead have now entered into a binding agreement to collaborate on advancing gamgertamig (BCMAxCD3 T cell engager) in autoimmune diseases. This agreement comes after the companies announced their advanced discussions on the collaboration last week. Economically, Galapagos is effectively co-fina...
- Guy Sips
- Jacob Mekhael
- Mathijs Geerts Danau
- Wim Lewi
Galapagos en Gilead gaan definitieve overeenkomst aan over samenwerkin...
Galapagos en Gilead gaan definitieve overeenkomst aan over samenwerking om een first-in-class T-cel-engagerprogramma voor auto-immuunziekten verder te ontwikkelen De nieuwe samenwerkingsstructuur levert aanzienlijk verbeterde financiële voorwaarden en flexibiliteit voor Galapagos op Na deze transactie blijft de Vennootschap over het grootste deel van haar liquide middelen beschikken voor bijkomende strategische transacties en andere prioriteiten van kapitaalallocatie Kans om met gamgertamig een potentieel first-in-class & best-in-class T-cell-engager in auto-immuunziekten te ontwikkelen ...
Galapagos and Gilead Enter into Binding Agreement to Collaborate on Ad...
Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases New collaboration structure achieves meaningfully improved financial terms and flexibility for Galapagos Following this transaction, the Company will continue to have a majority of its cash remaining for additional strategic transactions and other capital allocation priorities Opportunity to develop a potential first-in-class & best-in-class T cell engager in autoimmune diseases with gamgertamig Management to host conference call today, March 31, 20...
- Guy Sips
- Hilde Van Boxstael
- Jacob Mekhael
- Livio Luyten
- Michiel Declercq
- Wim Lewi
GSR signs Memorandum of Understanding with Japan’s DORD to conduct joi...
GSR signs Memorandum of Understanding with Japan’s DORD to conduct joint demonstration test in the Clarion-Clipperton Zone Global Sea Mineral Resources (GSR), the deep‑sea exploratory subsidiary of DEME, has signed a Memorandum of Understanding (MOU) with Deep Ocean Resources Development Co., Ltd. (DORD) of Japan to conduct a joint demonstration test aimed at the potential co-development of polymetallic nodule resources within DORD’s exploration license area in Clarion‑Clipperton Zone (CCZ). Under the MOU, GSR will provide its technical knowledge and operational expertise to support DORD’s ...
GSR ondertekent Memorandum of Understanding met het Japanse DORD voor ...
GSR ondertekent Memorandum of Understanding met het Japanse DORD voor gezamenlijke demonstratietest in de Clarion‑Clipperton Zone Global Sea Mineral Resources (GSR), de diepzee‑exploratiedochter van DEME, heeft een Memorandum of Understanding (MoU) ondertekend met het Japanse Deep Ocean Resources Development Co., Ltd. (DORD) voor de uitvoering van een gezamenlijke demonstratietest. Deze test is gericht op de mogelijke gezamenlijke ontwikkeling van polymetaalknollen binnen het exploratievergunningsgebied van DORD in de Clarion‑Clipperton Zone (CCZ). In het kader van het MoU zal GSR zijn tech...
Galapagos kondigt de voordracht aan van Gino Santini tot lid van de Ra...
Galapagos kondigt de voordracht aan van Gino Santini tot lid van de Raad van Bestuur De Raad van Bestuur is voornemens de heer Santini te benoemen tot Voorzitter, als opvolger van Jérôme Contamine, onder voorbehoud van zijn benoeming door aandeelhouders De heer Santini zal uitgebreide ervaring op het gebied van corporate governance, bedrijfsontwikkeling en leiderschap in de sector toevoegen aan de Raad van Bestuur Mechelen, België; 26 maart, 2026, 21:02 CET — Galapagos NV (Euronext & NASDAQ: GLPG), heeft vandaag bekendgemaakt dat Gino Santini is voorgedragen als Niet-Uitvoerend Onafhankel...
Galapagos Announces Nomination of Gino Santini to its Board of Directo...
Galapagos Announces Nomination of Gino Santini to its Board of Directors Subject to his election by shareholders, the Board intends to appoint Mr. Santini as Chair, succeeding Jérôme Contamine Mr. Santini will bring extensive corporate governance, business development and industry leadership experience to the Board Mechelen, Belgium; March 26, 2026, 21:02 CET — Galapagos NV (Euronext & NASDAQ: GLPG), today announced the proposed appointment of Gino Santini as a Non-Executive Independent Director, with the intention to appoint him as Chair of its Board of Directors, subject to shareholder...
Galapagos Publishes 2025 Annual Report and Announces Annual and Extrao...
Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders’ Meetings Mechelen, Belgium; March 26, 2026, 21:01 CET; regulated information — Galapagos NV (Euronext & NASDAQ: GLPG) today published its annual report for the financial year 2025 and announced that its Annual Shareholders’ Meeting (AGM) and an Extraordinary Shareholders' Meeting (EGM) will be held sequentially on Tuesday, April 28, 2026 at 14:00 CET and 15:00 CET at Schaliënhoevedreef 20T, 2800 Mechelen, Belgium. The annual report for the financial year 2025, including a review of figures and perfo...
Galapagos publiceert 2025 jaarverslag en kondigt de Gewone (jaarlijkse...
Galapagos publiceert 2025 jaarverslag en kondigt de Gewone (jaarlijkse) en Buitengewone Algemene Vergaderingen aan Mechelen, België; 26 maart, 2026, 21:01 CET; gereglementeerde informatie — Galapagos NV (Euronext & NASDAQ: GLPG) heeft vandaag haar jaarverslag over het boekjaar 2025 gepubliceerd en aangekondigd dat haar Gewone (jaarlijkse) Algemene Vergadering (GAV) en een Buitengewone Algemene Vergadering (BAV) achtereenvolgens zullen plaatsvinden op dinsdag 28 april 2026 om 14.00 uur en 15.00 uur te Schaliënhoevedreef 20T, 2800 Mechelen, België. Het jaarverslag over het boekjaar 2025, inc...
DEME: publication of the Annual Report 2025
DEME: publication of the Annual Report 2025 DEME today released its Annual Report 2025, which provides a comprehensive overview of the group’s strategy, operational performance, ESG progress, and financial results. It is the fourth such report since the company's stock listing in 2022. As announced at the end of February 2026, last year proved to be yet another record year for DEME, with all-time high profitability, building on the strong momentum of previous years. 2026 is also shaping up to be a milestone year as DEME is celebrating its 150th anniversary. Attachment ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.